Wang Xinlin, Gao Xianchun, Yu Jun, Zhang Xiaotian, Nie Yongzhan
State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Xi'an, Shaanxi 710032, China.
National Clinical Research Center for Digestive Diseases, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an, Shaanxi 710032, China.
Chin Med J (Engl). 2024 Aug 15;137(18):2146-56. doi: 10.1097/CM9.0000000000003259.
The incidence of early-onset gastric cancer (EOGC) is consistently increasing, and its etiology is notably complex. This increase may be attributed to distinctive factors that differ from those associated with late-onset gastric cancer (LOGC), including genetic predispositions, dietary factors, gastric microbiota dysbiosis, and screening of high-risk cases. These factors collectively contribute to the onset of cancer. EOGC significantly differs from LOGC in terms of clinicopathological and molecular characteristics. Moreover, multiple differences in prognosis and clinical management also exist. This study aimed to systematically review the latest research advancements in the epidemiological characteristics, etiological factors, clinicopathological and molecular features, prognosis, and treatment modalities of EOGC.
早发性胃癌(EOGC)的发病率持续上升,其病因极为复杂。这种上升可能归因于与晚发性胃癌(LOGC)相关因素不同的独特因素,包括遗传易感性、饮食因素、胃微生物群失调以及高危病例筛查。这些因素共同促成了癌症的发生。EOGC在临床病理和分子特征方面与LOGC有显著差异。此外,在预后和临床管理方面也存在多种差异。本研究旨在系统综述EOGC在流行病学特征、病因、临床病理和分子特征、预后及治疗方式等方面的最新研究进展。